Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,851,022
+$1,219,338 QoQ
Shares Held
102,949
+281.7% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 71%
Shared 29%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tidal Investments LLC holds $283,741,503 across 82 Biotechnology names. URGN ranks #33 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
92,081 | $41,117,849 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
39,652 | $30,636,720 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,927 | $19,166,306 | |
| 4 | EXEL |
Exelixis, Inc.
|
382,343 | $16,398,690 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
137,242 | $13,346,784 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
167,598 | $10,831,857 | |
| 7 | INSM |
INSMED Inc
|
61,776 | $10,101,611 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
129,601 | $9,624,170 |
All Filings in URGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,851,022 | 102,949 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $631,684 | 26,972 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $328,249 | 29,679 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $325,101 | 30,526 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $477,456 | 37,595 | Shares | Defined | 2024-11-25 | |
| 2024-06-30 | $529,660 | 31,565 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $424,800 | 28,320 | Shares | Defined | 2024-05-16 | |
| No filing history on record for this holder in this stock. | ||||||